LM11A-31

From Wikipedia, the free encyclopedia

Other namesLM-11A-31
Legal status
  • Investigational
CAS Number
LM11A-31
Clinical data
Other namesLM-11A-31
Legal status
Legal status
  • Investigational
Identifiers
  • (2S,3S)-2-Amino-3-methyl-N-(2-morpholin-4-ylethyl)pentanamide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H25N3O2
Molar mass243.351 g·mol−1
3D model (JSmol)
  • CC[C@H](C)[C@@H](C(=O)NCCN1CCOCC1)N
  • InChI=1S/C12H25N3O2/c1-3-10(2)11(13)12(16)14-4-5-15-6-8-17-9-7-15/h10-11H,3-9,13H2,1-2H3,(H,14,16)/t10-,11-/m0/s1
  • Key:YNMUTYLWSRFTPX-QWRGUYRKSA-N

LM11A-31 is an experimental drug developed for Alzheimer's disease and Huntington's disease.[1][2][3][4][5][6][7][8]

Related Articles

Wikiwand AI